|
|
| | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate Basic information |
| Product Name: | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate | | Synonyms: | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate;5-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2-pyridinecarboxylic acid methyl ester;2-Pyridinecarboxylic acid, 5-[[[(2,4-difluorophenyl)methyl]amino]carbonyl]-1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-, methyl ester;methyl5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dirnethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate | | CAS: | 1616340-68-1 | | MF: | C20H22F2N2O7 | | MW: | 440.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1616340-68-1.mol |  |
| | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate Chemical Properties |
| Boiling point | 611.5±55.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 10.99±0.40(Predicted) |
| | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate Usage And Synthesis |
| Uses | 5-?[[[(2,?4-?Difluorophenyl)?methyl]?amino]?carbonyl]?-?1-?(2,?2-?dimethoxyethyl)?-?1,?4-?dihydro-?3-?methoxy-?4-?oxo-2-pyridinecarboxylic Acid Methyl Ester is an intermediate in the synthesis of Cabotegravir-d3 (C050102), which is the labelled form of Cabotegravir (C050100). Cabotegravir is a long acting HIV-1 integrase inhibitor with action against a broad range of HIV subtypes. |
| | Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate Preparation Products And Raw materials |
|